Evaluation of the effect of metoclopramide on the mucosal nausea reflex caused by molding

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190223042808N1

Enrollment

Registered

2019-06-03

Start date

2019-03-03

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea reflux.

Interventions

Intervention group: One group was considered to have reported nausea reflexes before and after using metoclopramide drop..

Eligibility

Sex/Gender

All

Age

25 Years to 56 Years

Inclusion criteria

Inclusion criteria: Patients should be healthy in health, without any history of drug or allergic allergies None of the contraindications and precautions for metoclopramide use (such as history of seizure, history of gastrointestinal bleeding, etc.) Do not take a drug that interferes with metoclopramide (eg, phenotyazine, antidepressants, aspirin, acetaminophen, etc.) These patients lacked stress and had a poor history of receiving dental care

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Nausea during molding. Timepoint: Periods of measurement of nausea reflux in the beginning of the study (before the intervention) and half an hour after the use of metoclopramide drop. Method of measurement: Using the 20-point ruler, the Visual Analogue Scale is set.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPantea Riahi

Islamic Azad University

panteariahi@gmail.com+98 26 3440 4721

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026